Correlation Between HUT 8 and ASTELLAS PHARMA

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both HUT 8 and ASTELLAS PHARMA at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining HUT 8 and ASTELLAS PHARMA into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between HUT 8 P and ASTELLAS PHARMA UNSPADR, you can compare the effects of market volatilities on HUT 8 and ASTELLAS PHARMA and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in HUT 8 with a short position of ASTELLAS PHARMA. Check out your portfolio center. Please also check ongoing floating volatility patterns of HUT 8 and ASTELLAS PHARMA.

Diversification Opportunities for HUT 8 and ASTELLAS PHARMA

-0.84
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between HUT and ASTELLAS is -0.84. Overlapping area represents the amount of risk that can be diversified away by holding HUT 8 P and ASTELLAS PHARMA UNSPADR in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ASTELLAS PHARMA UNSPADR and HUT 8 is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on HUT 8 P are associated (or correlated) with ASTELLAS PHARMA. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ASTELLAS PHARMA UNSPADR has no effect on the direction of HUT 8 i.e., HUT 8 and ASTELLAS PHARMA go up and down completely randomly.

Pair Corralation between HUT 8 and ASTELLAS PHARMA

Assuming the 90 days horizon HUT 8 P is expected to generate 3.92 times more return on investment than ASTELLAS PHARMA. However, HUT 8 is 3.92 times more volatile than ASTELLAS PHARMA UNSPADR. It trades about 0.06 of its potential returns per unit of risk. ASTELLAS PHARMA UNSPADR is currently generating about -0.02 per unit of risk. If you would invest  1,510  in HUT 8 P on August 25, 2024 and sell it today you would earn a total of  800.00  from holding HUT 8 P or generate 52.98% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

HUT 8 P  vs.  ASTELLAS PHARMA UNSPADR

 Performance 
       Timeline  
HUT 8 P 

Risk-Adjusted Performance

16 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in HUT 8 P are ranked lower than 16 (%) of all global equities and portfolios over the last 90 days. Despite nearly uncertain basic indicators, HUT 8 reported solid returns over the last few months and may actually be approaching a breakup point.
ASTELLAS PHARMA UNSPADR 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days ASTELLAS PHARMA UNSPADR has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fragile performance in the last few months, the Stock's technical indicators remain nearly stable which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long-run up-swing for the company stockholders.

HUT 8 and ASTELLAS PHARMA Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with HUT 8 and ASTELLAS PHARMA

The main advantage of trading using opposite HUT 8 and ASTELLAS PHARMA positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if HUT 8 position performs unexpectedly, ASTELLAS PHARMA can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ASTELLAS PHARMA will offset losses from the drop in ASTELLAS PHARMA's long position.
The idea behind HUT 8 P and ASTELLAS PHARMA UNSPADR pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.

Other Complementary Tools

Global Correlations
Find global opportunities by holding instruments from different markets
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Equity Valuation
Check real value of public entities based on technical and fundamental data
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA